Analysis Bangkok Dusit Medical Services Public Co., Ltd. (BDUUF)
6/4/2024
Analysis of Bangkok Dusit Medical Services Public Co., Ltd. (BDUUF)
Bangkok Dusit Medical Services Public Co., Ltd. (BDUUF) has shown a consistent uptrend in its stock price over the past few days, with the price closing at 0.77 on the most recent trading day. The Relative Strength Index (RSI) is indicating overbought conditions, reaching almost 100, which may suggest a potential reversal or correction in the near future.The Moving Average Convergence Divergence (MACD) indicator is showing a positive trend, with the MACD line above the signal line and a positive MACD histogram. This indicates bullish momentum in the stock price.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, supporting the bullish outlook for the stock.
Overall, based on the technical indicators, BDUUF appears to be in a strong bullish trend, but traders should be cautious of the overbought RSI levels and potential for a correction in the short term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a projected sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates has increased to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant growth of 6% from the previous fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly more optimistic outlook for the next fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still expected to be healthy.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the current price of $192.25 is below both the median and average predicted prices. The analysts' predictions suggest a potential increase in the price of the security, with a high estimate of $275. Investors may interpret this information as a signal that the security could be undervalued at its current price, potentially presenting a buying opportunity. However, it's important to conduct further research and analysis before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at this time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The stock has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The company's market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, 200-day moving average of $181.04, and a 52-week range from $164.08 to $199.62.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a trailing annual dividend yield of 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general trend of increasing revenue over the years.
- The largest increase in revenue was seen from FY 2020 to FY 2021.
These trends in revenue can provide insights into the company's performance and market conditions over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing over the years, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance, and payments, with significant fluctuations in values.
6. Investing activities indicate a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
MACD of BDUUF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
